Abstract
Blood flow restoration by percutaneous coronary intervention (PCI) is currently one of the main approaches to the treatment of patients with acute myocardial infarction. However, suboptimal coronary reperfusion associated with microvascular obstruction (no-slow-reflow phenomenon) may occur in 30–60% of cases after PCI. This review presents an analysis of the effect of statin therapy on the risk of no-slow-reflow and clinical prognosis in patients after PCI.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
